FDA issues draft guidance on nanotechnology
date:Apr 26, 2012
ify properties of nanomaterials and assess the impact they may have on products.
Understanding nanotechnology remains a top FDA priority. FDA is strengthening the scientific tools and methods for evaluating food products, cosmetics, drugs and medical devices, said FDA Commissioner Margaret A. Hamburg, M.D. We are taking a prudent scientific approach to assess each product on its own merits and to not make broad, general assumptions about the safety of nanotechnology products.

The FDAs current t
6/8 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/01 11:13